Showing results (101-110 of 107) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
JCO Precision Oncology|September 11, 2019
Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function MutationsB A Carneiro, K A Collier, R J Nagy, et al.Biochemistry|September 16, 1997
Structure-function relationships in Anabaena ferredoxin: correlations between X-ray crystal structures, reduction potentials, and rate constants of electron transfer to ferredoxin:NADP+ reductase for site-specific ferredoxin mutantsJ K Hurley, A M Weber-Main, M T Stankovich, et al.Journal for Immunotherapy of Cancer|February 20, 2026
QVT score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapyYoung K Chae, Vamsidhar Velcheti, Kai Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Anaplastic Lymphoma Kinase Mutation (ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to AlectinibBenedito A Carneiro, Sahithi Pamarthy, Ami N Shah, et al.Physical Review Letters|May 20, 2022
Constraining the ^{30}P(p, γ)^{31}S Reaction Rate in ONe Novae via the Weak, Low-Energy, β-Delayed Proton Decay of ^{31}ClT Budner, M Friedman, C Wrede, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2020
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol WYoung K Chae, Fangxin Hong, Christos Vaklavas, et al.The Lancet. Oncology|December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trialsAlexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.Pageof 11